Published February 6, 2024
| Version v1
Dataset
Open
Ipilimumab and nivolumab first-line therapy in BRAF-mutated metastatic melanoma patients is protective for the occurrence of new brain metastasis.
Authors/Creators
Description
5-years OS, TPFS, BMFS, SABM and biomakers of SECOMBIT trial.
Files
Files
(28.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:dcd7ebb9851bda0f71bfa4cee58069ef
|
28.0 kB | Download |
Additional details
Dates
- Updated
-
2024-02-06